{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T08:14:45Z","timestamp":1782634485764,"version":"3.54.5"},"reference-count":117,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1053\/j.semdp.2019.12.006","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T21:18:43Z","timestamp":1576790323000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Updates in lymph node and skin pathology of adult T-cell leukemia\/lymphoma, biomarkers, and beyond"],"prefix":"10.1053","volume":"37","author":[{"given":"Brian D.","family":"Adkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Bliss-Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2019.12.006_bib0001","year":"2017"},{"key":"10.1053\/j.semdp.2019.12.006_bib0002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-Cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0003","article-title":"Cutaneous manifestations of adult T-cell leukemia\/lymphoma","author":"Miyashiro","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0004","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1053\/j.semdp.2019.12.006_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1\u2013related atll in an area of prevalence in the united states","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv"},{"key":"10.1053\/j.semdp.2019.12.006_bib0006","article-title":"Epidemiology and survival trend of adult T-cell leukemia\/lymphoma in the united states","author":"Shah","year":"2019","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2019.12.006_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-Cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0008","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2223\/JPED.1573","article-title":"Manifesta\u00e7\u00f5es infanto-juvenis da infec\u00e7\u00e3o pelo v\u00edrus linfotr\u00f3pico de c\u00e9lulas t humanas (HTLV-I)","volume":"82","author":"Bittencourt","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1053\/j.semdp.2019.12.006_bib0009","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related atll in an area of prevalence in the united states","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv"},{"key":"10.1053\/j.semdp.2019.12.006_bib0010","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V98.6.1858","article-title":"CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type i","volume":"98","author":"Nagai","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0011","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.2910430214","article-title":"Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I","volume":"43","author":"Murphy","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2019.12.006_bib0012","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3109\/10428194.2014.964700","article-title":"The incidence of adult T-cell leukemia\/lymphoma among human T-lymphotropic virus type 1 carriers in japan","volume":"56","author":"Satake","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.006_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tracli.2015.12.001","article-title":"Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): implications for blood transfusion safety","volume":"23","author":"Murphy","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0014","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3389\/fmicb.2019.00999","article-title":"Mother-to-Child HTLV-1 transmission: unmet research needs","volume":"10","author":"Rosadas","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/aid.2011.0342","article-title":"Retroviral coinfections: hiv and HTLV: taking stock of more than a quarter century of research.","volume":"28","author":"Beilke","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1053\/j.semdp.2019.12.006_bib0016","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"members of the lymphoma study G. diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0017","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/jcp.2007.052456","article-title":"Adult T-cell leukaemia\/lymphoma","volume":"60","author":"Matutes","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0018","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How i treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1346-8138.12374","article-title":"Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma","volume":"41","author":"Tsukasaki","year":"2014","journal-title":"J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annder.2018.01.049","article-title":"Cutaneous presentation of adult T-cell leukemia\/lymphoma (ATLL). single-center study on 37 patients in metropolitan france between 1996 and 2016","volume":"145","author":"Hurabielle","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0021","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0022","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaad.2009.10.021","article-title":"Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review","volume":"64","author":"Lee","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.det.2013.11.006","article-title":"Infective dermatitis associated with HTLV-1 mimics common eczemas in children and may be a prelude to severe systemic diseases","volume":"32","author":"Hlela","year":"2014","journal-title":"Dermatol Clin"},{"key":"10.1053\/j.semdp.2019.12.006_bib0024","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-4632.2011.04882.x","article-title":"Human T-lymphotropic virus 1 (HTLV-1) infection\u2013dermatological implications","volume":"50","author":"Amano","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0025","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4269\/ajtmh.2005.72.855","article-title":"Norwegian scabies in peru: the impact of human t cell lymphotropic virus type i infection","volume":"72","author":"Blas","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1053\/j.semdp.2019.12.006_bib0026","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-4632.2008.03707.x","article-title":"Scabies superimposed on skin lesions of adult T-cell leukemia\/lymphoma: case report and literature review","volume":"47","author":"Kabashima","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0027","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5858\/arpa.2012-0379-RS","article-title":"Adult T-Cell leukemia\/lymphoma","volume":"138","author":"Qayyum","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2019.12.006_bib0028","series-title":"Adult T-cell leukemia\/lymphoma","first-page":"619","author":"Yoshino","year":"2016"},{"key":"10.1053\/j.semdp.2019.12.006_bib0029","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10428190009087029","article-title":"Human T-lymphotropic virus type i provirus and T-cell prolymphocytic leukemia","volume":"38","author":"Kojima","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.006_bib0030","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1349-7006.2007.00456.x","article-title":"Pathological features of diseases associated with human T-cell leukemia virus type i","volume":"98","author":"Ohshima","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2019.12.006_bib0031","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/imj.12394","article-title":"Adult T-cell leukaemia\/lymphoma can mimic other lymphomas in a non-endemic area: dilemmas in diagnosis and treatment","volume":"44","author":"Huang","year":"2014","journal-title":"Intern Med J"},{"key":"10.1053\/j.semdp.2019.12.006_bib0032","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2017-11-817106","article-title":"Chewing the bone: bone marrow with adult T-cell leukemia\/lymphoma","volume":"131","author":"Siref","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0033","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1993.tb00223.x","article-title":"HTLV-1-associated cutaneous disease: a clinicopathoiogical and molecular study of patients from the U. k","volume":"128","author":"Whittaker","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0034","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000478-198404000-00003","article-title":"The pathologic spectrum of adult T-cell leukemia\/lymphoma in the united states. human T-cell leukemia\/lymphoma virus-associated lymphoid malignancies","volume":"8","author":"Jaffe","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0036","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1309\/KEN4MXM5Y9A1GEMP","article-title":"Flow cytometric immunophenotyping of adult T-Cell leukemia\/lymphoma using CD3 gating","volume":"124","author":"Yokote","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0037","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/AJCPS1K0OHLJYWWV","article-title":"Minimal residual disease detection by flow cytometry in adult T-Cell leukemia\/lymphoma","volume":"133","author":"Shao","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0038","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/pin.12040","article-title":"CD4 and CD8 double-negative adult T-cell leukemia\/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus","volume":"63","author":"Lin","year":"2013","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2019.12.006_bib0039","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000323163","article-title":"Dual-Positive (CD4+\/CD8+) acute adult T-Cell leukemia\/lymphoma associated with complex karyotype and refractory hypercalcemia: case report and literature review","volume":"3","author":"Raza","year":"2010","journal-title":"Case Rep Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0040","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22536","article-title":"Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells","volume":"120","author":"Yano","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2019.12.006_bib0041","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e31828f2322","article-title":"Loss of foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia\/lymphoma (ATLL) in US\/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy","volume":"37","author":"Yao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0042","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-18-0268","article-title":"CD30 characterizes polylobated lymphocytes and disease progression in HTLV-1-Infected individuals","volume":"24","author":"Nakashima","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2019.12.006_bib0043","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2019.12.006_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bjd.16322","article-title":"KIR3DL2 expression in patients with adult T-cell lymphoma\/leukaemia","volume":"179","author":"Hurabielle","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cam4.928","article-title":"Risk stratification of adult T-cell leukemia\/lymphoma using immunophenotyping","volume":"6","author":"Kagdi","year":"2017","journal-title":"Cancer Med"},{"key":"10.1053\/j.semdp.2019.12.006_bib0046","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with atl","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0047","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2019.12.006_bib0048","doi-asserted-by":"crossref","first-page":"e53728","DOI":"10.1371\/journal.pone.0053728","article-title":"The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-i","volume":"8","author":"Kobayashi","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2019.12.006_bib0049","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2559.2008.03199.x","article-title":"Loss of CD7, independent of galectin-3 expression, implies a worse prognosis in adult T-cell leukaemia\/lymphoma","volume":"54","author":"Liu","year":"2009","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2019.12.006_bib0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected t cells.","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0051","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hon.2900080207","article-title":"Rearrangement of human t cell receptor beta and gamma chain genes in adult t cell leukemia\/lymphoma","volume":"8","author":"Ohshima","year":"1990","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0052","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of htlv-i provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0053","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V63.5.1235.1235","article-title":"The detection of human t cell leukemia virus proviral dna and its application for classification and diagnosis of t cell malignancy","volume":"63","author":"Yamaguchi","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0054","article-title":"Molecular biology of human t cell leukemia virus","author":"Ratner","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmicb.2012.00247","article-title":"HBZ and its roles in HTLV-1 oncogenesis","volume":"3","author":"Zhao","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0056","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult t cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.12.006_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fmicb.2018.00285","article-title":"HTLV deregulation of the nf-\u03bab pathway: an update on tax and antisense proteins role","volume":"9","author":"Fochi","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0058","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.it.2013.02.002","article-title":"A new look at t cell receptor signaling to nuclear factor-\u03baB","volume":"34","author":"Paul","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0059","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2019.12.006_bib0060","first-page":"417","article-title":"[Genetic landscape of adult T-cell leukemia\/lymphoma]","volume":"57","author":"Kataoka","year":"2016","journal-title":"Rinsho Ketsueki"},{"key":"10.1053\/j.semdp.2019.12.006_bib0061","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1014471500757","article-title":"Genetic instability of adult T-cell leukemia\/lymphoma by comparative genomic hybridization analysis","volume":"22","author":"Tsukasaki","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0062","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","article-title":"Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: correlation with clinical course","volume":"97","author":"Tsukasaki","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0063","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2010-12-327791","article-title":"Clonal evolution of adult T-cell leukemia\/lymphoma takes place in the lymph nodes","volume":"117","author":"Umino","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0064","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-62703-281-0_12","article-title":"Array cgh reveals clonal evolution of adult T-cell leukemia\/lymphoma","volume":"973","author":"Umino","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0065","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2019.12.006_bib0066","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous t cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.12.006_bib0067","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous t cell lymphoma and sezary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.12.006_bib0068","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.semdp.2016.11.002","article-title":"A new molecular paradigm in mycosis fungoides and sezary syndrome","volume":"34","author":"Elenitoba-Johnson","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0069","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and sezary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.12.006_bib0070","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-stat pathway in sezary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1053\/j.semdp.2019.12.006_bib0071","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated rhoa mutations in adult T-cell leukemia\/lymphoma","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0072","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces t follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2019.12.006_bib0073","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2019.12.006_bib0074","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to tcr signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0076","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.18632\/oncotarget.14846","article-title":"Angioimmunoblastic t cell lymphoma: novel molecular insights by mutation profiling","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1053\/j.semdp.2019.12.006_bib0077","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1128\/JVI.77.20.11170-11179.2003","article-title":"T-cell receptor\/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1","volume":"77","author":"Dumais","year":"2003","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0078","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of t cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0079","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2019.12.006_bib0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2019.12.006_bib0081","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.006_bib0082","first-page":"574","article-title":"[The microenvironment and immune status of peripheral T-cell lymphoma: focusing on aitl and ATLL]","volume":"59","author":"Ohshima","year":"2018","journal-title":"Rinsho Ketsueki"},{"key":"10.1053\/j.semdp.2019.12.006_bib0083","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1074\/jbc.RA117.000164","article-title":"An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia","volume":"293","author":"Cherian","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2019.12.006_bib0084","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-I-Regulated BATF3\/IRF4 transcriptional network in adult t cell leukemia\/lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2019.12.006_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.semdp.2019.12.006_bib0086","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jcb.20290","article-title":"Regulation of the GATA3 promoter by human T-cell lymphotropic virus type i tax protein","volume":"93","author":"Gilli","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.semdp.2019.12.006_bib0087","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 viral factor hbz induces CCR4 to promote T-cell migration and proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2019.12.006_bib0088","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0089","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0090","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0091","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 induces a Th1-like state in CD4+CCR4+ t cells","volume":"124","author":"Araya","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2019.12.006_bib0092","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","article-title":"Tax-inducible production of cc chemokine ligand 22 by human t cell leukemia virus type 1 (HTLV-1)-infected t cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ t cells","volume":"180","author":"Hieshima","year":"2008","journal-title":"J Immunol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0093","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2019.12.006_bib0094","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11899-018-0458-6","article-title":"Adult t cell leukemia-lymphoma (ATL): state of the art","volume":"13","author":"Phillips","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1053\/j.semdp.2019.12.006_bib0095","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3389\/fmicb.2018.01686","article-title":"HTLV-1-Mediated epigenetic pathway to adult T-Cell leukemia-lymphoma","volume":"9","author":"Yamagishi","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0096","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North american atll has a distinct mutational and transcriptional profile and responds to epigenetic therapies","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0097","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/1806-9282.62.07.691","article-title":"Adult T-cell leukemia\/lymphoma","volume":"62","author":"Oliveira","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1053\/j.semdp.2019.12.006_bib0098","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2230.2011.04141.x","article-title":"Cutaneous type adult T-cell leukaemia\/lymphoma successfully treated with narrowband ultraviolet b phototherapy","volume":"37","author":"Kudo","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0099","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1365-2133.1995.tb06933.x","article-title":"Satisfactory remission achieved by puva therapy in a case of crisis-type adult T-cell leukaemia\/lymphoma with generalized cutaneous leukaemic cell infiltration","volume":"133","author":"Takemori","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/10428194.2012.715351","article-title":"Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia\/lymphoma with skin involvement","volume":"54","author":"Sawada","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.006_bib0101","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0102","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.50.9","article-title":"Treatment of adult T-cell leukemia","volume":"50","author":"Uozumi","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"10.1053\/j.semdp.2019.12.006_bib0103","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3816\/CLM.2003.n.027","article-title":"Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia\/lymphoma","volume":"4","author":"Di Venuti","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.006_bib0104","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly chop for adult T-cell leukemia-lymphoma: japan clinical oncology group study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2019.12.006_bib0106","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transpl"},{"key":"10.1053\/j.semdp.2019.12.006_bib0107","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bbmt.2019.05.027","article-title":"Efficacy of allogeneic hematopoietic cell transplantation in human t cell lymphotropic virus type 1-Associated adult t cell leukemia\/lymphoma: results of a systematic review\/meta-analysis","volume":"25","author":"Iqbal","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1053\/j.semdp.2019.12.006_bib0108","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/bmt.2016.154","article-title":"Striving to cure adult T-cell leukaemia\/lymphoma: a role for allogeneic stem cell transplant?","volume":"51","author":"Phillips","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"10.1053\/j.semdp.2019.12.006_bib0109","first-page":"2190","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma","volume":"57","author":"Utsunomiya","year":"2016","journal-title":"Rinsho Ketsueki"},{"key":"10.1053\/j.semdp.2019.12.006_bib0110","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0111","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-ccr4 monoclonal antibody (KW-0761) for relapsed adult T-Cell leukemia-lymphoma: a multicenter phase ii study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.006_bib0112","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3324\/haematol.2018.214536","article-title":"Mogamulizumab versus investigator choice in relapsed\/refractory adult T-cell leukemia\/lymphoma: all four one or none for all","volume":"104","author":"Johnson","year":"2019","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2019.12.006_bib0113","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3324\/haematol.2018.205096","article-title":"Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"104","author":"Phillips","year":"2019","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2019.12.006_bib0114","first-page":"21","article-title":"Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy","volume":"11","author":"Oka","year":"2019","journal-title":"Leuk Res Rep"},{"key":"10.1053\/j.semdp.2019.12.006_bib0115","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1056\/NEJMc1803181","article-title":"Rapid progression of adult T-Cell leukemia\u2013lymphoma after PD-1 inhibitor therapy","volume":"378","author":"Ratner","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2019.12.006_bib0116","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1182\/blood.V120.21.2706.2706","article-title":"CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-Cell leukemia\/lymphoma presenting outside of Japan","volume":"120","author":"Lunning","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.006_bib0117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-16-1022","article-title":"Phase ii study of alemtuzumab (CAMPATH-1) in patients with HTLV-1-Associated adult T-cell leukemia\/lymphoma","volume":"23","author":"Sharma","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:20:55Z","timestamp":1760037655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257019301145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0740257019301145"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.006","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in lymph node and skin pathology of adult T-cell leukemia\/lymphoma, biomarkers, and beyond","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}